HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of erythrodermic psoriasis in which adalimumab injection sites are preserved.

AuthorsIlknur Ozcan, Ayse Serap Karadag, Eylem Ceren, Busra Demirci, Filiz Cebeci
JournalDermatologic therapy (Dermatol Ther) Vol. 34 Issue 2 Pg. e14865 (03 2021) ISSN: 1529-8019 [Electronic] United States
PMID33569858 (Publication Type: Case Reports, Letter)
Chemical References
  • Adalimumab
Topics
  • Adalimumab (adverse effects, therapeutic use)
  • Dermatitis, Exfoliative (chemically induced, diagnosis)
  • Humans
  • Psoriasis (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: